Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00730_DB01418> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00730_DB01418 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00730_DB01418 label "DDI between Thiabendazole and Acenocoumarol - The strong CYP1A2 inhibitor, Thiabendazole, may increase the effects and toxicity of Acenocoumarol by decreasing Acenocoumarol metabolism and clearance. Monitor for changes in the therapeutic and adverse effects of Acenocoumarol if Thiabendazole is initiated, discontinued or dose changed. [drugbank_resource:DB00730_DB01418]" assertion.
- drugbank_resource:DB00730_DB01418 identifier "drugbank_resource:DB00730_DB01418" assertion.
- drugbank_resource:DB00730_DB01418 title "DDI between Thiabendazole and Acenocoumarol - The strong CYP1A2 inhibitor, Thiabendazole, may increase the effects and toxicity of Acenocoumarol by decreasing Acenocoumarol metabolism and clearance. Monitor for changes in the therapeutic and adverse effects of Acenocoumarol if Thiabendazole is initiated, discontinued or dose changed." assertion.